{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:48:31Z","timestamp":1790700511319,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1093\/ije\/31.5.1001","type":"journal-article","created":{"date-parts":[[2002,11,15]],"date-time":"2002-11-15T23:03:15Z","timestamp":1037401395000},"page":"1001-1007","source":"Crossref","is-referenced-by-count":28,"title":["Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore"],"prefix":"10.1093","volume":"31","author":[{"given":"Woon Puay","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C W","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Phoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K L","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent TK","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,10]]},"reference":[{"key":"key\n\t\t\t\t20170712065402_R1","doi-asserted-by":"crossref","unstructured":"Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med1986;315:161\u201368.","DOI":"10.1056\/NEJM198607173150305"},{"key":"key\n\t\t\t\t20170712065402_R2","doi-asserted-by":"crossref","unstructured":"Campbell LA, Kuo CC, Grayston JT. Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA\u2013DNA hybridization. J Clin Microbiol1987;25:1911\u201316.","DOI":"10.1128\/JCM.25.10.1911-1916.1987"},{"key":"key\n\t\t\t\t20170712065402_R3","doi-asserted-by":"crossref","unstructured":"Grayston JT, Campbell LA, Kuo CC et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis1990;161:618\u201325.","DOI":"10.1093\/infdis\/161.4.618"},{"key":"key\n\t\t\t\t20170712065402_R4","doi-asserted-by":"crossref","unstructured":"Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis2000;181(Suppl.3):S402\u201310.","DOI":"10.1086\/315596"},{"key":"key\n\t\t\t\t20170712065402_R5","doi-asserted-by":"crossref","unstructured":"Blasi F, Legnani D, Lombardo VM et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J1993;6:19\u201322.","DOI":"10.1183\/09031936.93.06010019"},{"key":"key\n\t\t\t\t20170712065402_R6","unstructured":"Tan YK, Ling AE, Lin RV, Ong YY, Wong SY. Two cases of lower respiratory tract infection due to Chlamydia pneumoniae in Singapore. Ann Acad Med Singapore1995;24:863\u201366."},{"key":"key\n\t\t\t\t20170712065402_R7","doi-asserted-by":"crossref","unstructured":"Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA1991;266:225\u201330.","DOI":"10.1001\/jama.266.2.225"},{"key":"key\n\t\t\t\t20170712065402_R8","unstructured":"Lee J, Saw SM, Mak KH, Hughes K, Chia KS, Lim YL. Infection and cardiovascular disease\u2014an epidemiological review. ASEAN Heart Journal2001;8:21\u201329."},{"key":"key\n\t\t\t\t20170712065402_R9","doi-asserted-by":"crossref","unstructured":"Hughes K, Lun KC, Yeo PP. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality. J Epidemiol Community Health1990;44:24\u201328.","DOI":"10.1136\/jech.44.1.24"},{"key":"key\n\t\t\t\t20170712065402_R10","unstructured":"Heng DM, Lee J, Chew SK, Tan BY, Hughes K, Chia KS. Incidence of ischaemic heart disease and stroke in Chinese, Malays and Indians in Singapore: Singapore Cardiovascular Cohort Study. Ann Acad Med Singapore2000;29:231\u201336."},{"key":"key\n\t\t\t\t20170712065402_R11","doi-asserted-by":"crossref","unstructured":"Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health1997;51:394\u201399.","DOI":"10.1136\/jech.51.4.394"},{"key":"key\n\t\t\t\t20170712065402_R12","doi-asserted-by":"crossref","unstructured":"Lee J, Heng D, Chia KS, Chew SK, Tan BY, Hughes K. Risk factors and incident coronary heart disease in Chinese, Malay and Asian Indian males: the Singapore Cardiovascular Cohort Study. Int J Epidemiol2001;30:983\u201388.","DOI":"10.1093\/ije\/30.5.983"},{"key":"key\n\t\t\t\t20170712065402_R13","unstructured":"Epidemiology and Disease Control Department, MOH, Singapore, National Health Survey 1998. 1999."},{"key":"key\n\t\t\t\t20170712065402_R14","doi-asserted-by":"crossref","unstructured":"Messmer TO, Martinez J, Hassouna F et al. Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae. Clin Diagn Lab Immunol2001;8:588\u201392.","DOI":"10.1128\/CDLI.8.3.588-592.2001"},{"key":"key\n\t\t\t\t20170712065402_R15","doi-asserted-by":"crossref","unstructured":"Chow VTK, Phoon MC. Seroepidemiological survey of Chlamydia pneumoniae infection among Singapore university undergraduates: comparison between microimmunofluorescence and neutralisation tests. World J Microbiol Biotechnol2001;17:773\u201378.","DOI":"10.1023\/A:1013515200484"},{"key":"key\n\t\t\t\t20170712065402_R16","doi-asserted-by":"crossref","unstructured":"Grayston JT, Golubjatnikov R, Hagiwara T et al. Serologic tests for Chlamydia pneumoniae. Pediatr Infect Dis J1993;12:790\u201391.","DOI":"10.1097\/00006454-199309000-00027"},{"key":"key\n\t\t\t\t20170712065402_R17","doi-asserted-by":"crossref","unstructured":"Dowell SF, Peeling RW, Boman J et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis2001;33:492\u2013503.","DOI":"10.1086\/322632"},{"key":"key\n\t\t\t\t20170712065402_R18","doi-asserted-by":"crossref","unstructured":"Ni AP, Lin GY, Yang L et al. A seroepidemiologic study of Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in different populations on the mainland of China. Scand J Infect Dis1996;28:553\u201357.","DOI":"10.3109\/00365549609037959"},{"key":"key\n\t\t\t\t20170712065402_R19","doi-asserted-by":"crossref","unstructured":"Wang JH, Liu YC, Cheng DL, Yeng MY, Chen YS, Chen BC. Seroprevalence of Chlamydia pneumoniae in Taiwan. Scand J Infect Dis1993;25:565\u201368.","DOI":"10.3109\/00365549309008544"},{"key":"key\n\t\t\t\t20170712065402_R20","doi-asserted-by":"crossref","unstructured":"Einarsson S, Sigurdsson HK, Magnusdottir SD, Erlendsdottir H, Briem H, Gudmundsson S. Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scand J Infect Dis1994;26:393\u201397.","DOI":"10.3109\/00365549409008610"},{"key":"key\n\t\t\t\t20170712065402_R21","doi-asserted-by":"crossref","unstructured":"Kanamoto Y, Ouchi K, Mizui M, Ushio M, Usui T. Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan. J Clin Microbiol1991;29:816\u201318.","DOI":"10.1128\/JCM.29.4.816-818.1991"},{"key":"key\n\t\t\t\t20170712065402_R22","doi-asserted-by":"crossref","unstructured":"Koivisto AL, Isoaho R, Von Hertzen L et al. Chlamydial antibodies in an elderly Finnish population. Scand J Infect Dis1999;31:135\u201339.","DOI":"10.1080\/003655499750006164"},{"key":"key\n\t\t\t\t20170712065402_R23","doi-asserted-by":"crossref","unstructured":"Choi TY, Kim DA, Kim SK, Kang JO, Park SS, Jung SR. Prevalence of specific antibodies to Chlamydia pneumoniae in Korea. J Clin Microbiol1998;36:3426\u201328.","DOI":"10.1128\/JCM.36.11.3426-3428.1998"},{"key":"key\n\t\t\t\t20170712065402_R24","unstructured":"Leowattana W, Mahanonda N, Bhuripanyo K, Pokum S. Seroprevalence of Chlamydia pneumoniae infection in Thailand. J Med Assoc Thai2000;83(Suppl.2):S1\u20135."},{"key":"key\n\t\t\t\t20170712065402_R25","doi-asserted-by":"crossref","unstructured":"Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect1992;25(Suppl.1):27\u201334.","DOI":"10.1016\/0163-4453(92)91913-V"},{"key":"key\n\t\t\t\t20170712065402_R26","doi-asserted-by":"crossref","unstructured":"Gencay M, Dereli D, Ertem E et al. Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey. Eur J Epidemiol1998;14:505\u201309.","DOI":"10.1023\/A:1007404315879"},{"key":"key\n\t\t\t\t20170712065402_R27","doi-asserted-by":"crossref","unstructured":"Grayston JT, Wang SP, Kuo CC, Campbell LA. Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis1989;8:191\u2013202.","DOI":"10.1007\/BF01965260"},{"key":"key\n\t\t\t\t20170712065402_R28","doi-asserted-by":"crossref","unstructured":"O\u2019Neill C, Murray LJ, Ong GM, O\u2019Reilly DP, Evans AE, Bamford KB. Epidemiology of Chlamydia pneumoniae infection in a randomly selected population in a developed country. Epidemiol Infect1999; 122:111\u201316.","DOI":"10.1017\/S0950268898001757"},{"key":"key\n\t\t\t\t20170712065402_R29","doi-asserted-by":"crossref","unstructured":"Aldous MB, Grayston JT, Wang SP, Foy HM. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966\u20131979. J Infect Dis1992;166:646\u201349.","DOI":"10.1093\/infdis\/166.3.646"},{"key":"key\n\t\t\t\t20170712065402_R30","doi-asserted-by":"crossref","unstructured":"Martinez MA, Kogan R, Silva JJ, Pinto ME, Vidal C, Huppo H. Seroprevalence of Chlamydia pneumoniae in Chile. Scand J Infect Dis1999;31:103\u201304.","DOI":"10.1080\/00365549950162005"},{"key":"key\n\t\t\t\t20170712065402_R31","doi-asserted-by":"crossref","unstructured":"Paltiel O, Kark JD, Leinonen M, Saikku P. High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol Infect1995;114:465\u201373.","DOI":"10.1017\/S0950268800052171"},{"key":"key\n\t\t\t\t20170712065402_R32","doi-asserted-by":"crossref","unstructured":"Gnarpe H, Gnarpe J. Increasing prevalence of specific antibodies to Chlamydia pneumoniae in Sweden. Lancet1993;341:381.","DOI":"10.1016\/0140-6736(93)90194-L"},{"key":"key\n\t\t\t\t20170712065402_R33","doi-asserted-by":"crossref","unstructured":"Ferrari M, Poli A, Olivieri M et al. Seroprevalence of Chlamydia pneumoniae antibodies in a young adult population sample living in Verona. European Community Respiratory Health Survey (ECRHS) Verona. Infection2000;28:38\u201341.","DOI":"10.1007\/s150100050009"},{"key":"key\n\t\t\t\t20170712065402_R34","doi-asserted-by":"crossref","unstructured":"Karvonen M, Tuomilehto J, Pitkaniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol1994;23:1315\u201321.","DOI":"10.1093\/ije\/23.6.1315"},{"key":"key\n\t\t\t\t20170712065402_R35","doi-asserted-by":"crossref","unstructured":"Cook PJ, Davies P, Wise R, Honeybourne D. Chlamydia pneumoniae infection and ethnic origin. Ethn Health1998;3:237\u201346.","DOI":"10.1080\/13557858.1998.9961866"},{"key":"key\n\t\t\t\t20170712065402_R36","doi-asserted-by":"crossref","unstructured":"Saikku P, Ruutu P, Leinonen M, Panelius J, Tupasi TE, Grayston JT. Acute lower-respiratory-tract infection associated with chlamydial TWAR antibody in Filipino children. J Infect Dis1988;158:1095\u201397.","DOI":"10.1093\/infdis\/158.5.1095"},{"key":"key\n\t\t\t\t20170712065402_R37","doi-asserted-by":"crossref","unstructured":"Shemer-Avni Y, Lieberman D. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. J Infect Dis1995;171:1274\u201378.","DOI":"10.1093\/infdis\/171.5.1274"},{"key":"key\n\t\t\t\t20170712065402_R38","doi-asserted-by":"crossref","unstructured":"Gnarpe J, Gnarpe H, Gause-Nilsson I, Lundorg P, Steen B. Seroprevalence of antibodies to Chlamydia pneumoniae in elderly people: a two-decade longitudinal and cohort difference study. Scand J Infect Dis2000;32:177\u201379.","DOI":"10.1080\/003655400750045295"},{"key":"key\n\t\t\t\t20170712065402_R39","doi-asserted-by":"crossref","unstructured":"Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscler Thromb1992;12:945\u201347.","DOI":"10.1161\/01.ATV.12.8.945"},{"key":"key\n\t\t\t\t20170712065402_R40","doi-asserted-by":"crossref","unstructured":"Goldberg RJ, Burchfiel CM, Benfante R, Chiu D, Reed DM, Yano K. Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-year findings from the Honolulu Heart Program. Arch Intern Med1995;155:686\u201394.","DOI":"10.1001\/archinte.1995.00430070036004"},{"key":"key\n\t\t\t\t20170712065402_R41","doi-asserted-by":"crossref","unstructured":"Leinonen M, Saikku P. Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis. Am Heart J1999;138:S504\u201306.","DOI":"10.1016\/S0002-8703(99)70286-3"},{"key":"key\n\t\t\t\t20170712065402_R42","doi-asserted-by":"crossref","unstructured":"Haberbosch W, Jantos C. Chlamydia pneumoniae infection is not an independent risk factor for arterial disease. Herz2000;25:79\u201383.","DOI":"10.1007\/PL00001955"},{"key":"key\n\t\t\t\t20170712065402_R43","doi-asserted-by":"crossref","unstructured":"Cook PJ, Lip GY, Davies P, Beevers DG, Wise R, Honeybourne D. Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension1998;31:589\u201394.","DOI":"10.1161\/01.HYP.31.2.589"},{"key":"key\n\t\t\t\t20170712065402_R44","doi-asserted-by":"crossref","unstructured":"Ekesbo R, Nilsson PM, Lindholm LH, Persson K, Wadstrom T. Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. J Cardiovasc Risk2000;7:191\u201395.","DOI":"10.1177\/204748730000700305"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/31\/5\/1001\/18479026\/311001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T12:48:43Z","timestamp":1682426923000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/31.5.1001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2002,10]]},"published-print":{"date-parts":[[2002,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/31.5.1001","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}